Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood
NCT ID: NCT04556630
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2020-12-09
2021-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 in ART: Perception and Experience
NCT04456010
Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
NCT04396210
Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle
NCT07028710
Pregnancy Outcomes of Patients Having NC-FET Regarding the Progesterone Levels
NCT05690360
Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients
NCT02293668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the cessation of assistance reproduction protocols related to the Covid-19 outbreak on March 13, 2020.
* acceptance of teleconsultation
Exclusion Criteria
I- ndividuals who do not respond to the questionnaire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bérengère DUCROCQ, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hop Calmette Chu Lille
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01810-39
Identifier Type: OTHER
Identifier Source: secondary_id
2020_65
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.